Jim Wassil

Executive Vice President and Chief Operating OfficeratVaxcyte· In proxies 2021–2025

Pay in FY2025-67% from the year before · Vaxcyte stock -43.6% the same year

Jim Wassil was paid $5.8M in FY2025 (Dec), down 67%. Vaxcyte stock fell 43.6% that year.

Pay$100 in the stock at the end of FY20 → $174

Pay is from the Summary Compensation Table of each Vaxcyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

PCVX
VaxcytePublic company · 5 yr
- Executive Vice President and Chief Operating Officer2021 – Present · 5 yrStock in role +120%

Roles come from the proxy statements of each company.

Activity

Pay
Vaxcyte COO pay fell 67% to $5.8M. The stock fell 44% in FY2025 (Dec).
DEF 14AApr 23, 2026
Pay
Vaxcyte COO pay rose 231% to $17.9M. The stock rose 30% in FY2024 (Dec).
DEF 14AApr 28, 2025
Pay
Vaxcyte COO pay fell 23% to $5.4M. The stock rose 31% in FY2023 (Dec).
DEF 14AApr 15, 2024
Pay
Vaxcyte COO pay rose 255% to $7.0M. The stock rose 102% in FY2022 (Dec).
DEF 14AApr 15, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?